Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Infection and Immunity|April 6, 2011
Potential of recombinant opa proteins as vaccine candidates against hyperinvasive meningococciM J Callaghan, S Lewis, M Sadarangani, et al.
Vaccine|September 5, 2018
Humoral and cellular immunity to RSV in infants, children and adultsC A Green, C J Sande, C de Lara, et al.
The Journal of Antimicrobial Chemotherapy|January 6, 2015
Dynamics of MDR Enterobacter cloacae outbreaks in a neonatal unit in Nepal: insights using wider sampling frames and next-generation sequencingN Stoesser, A E Sheppard, M Shakya, et al.
Genes and Immunity|October 26, 2007
Haplotypic diversity in human CEACAM genes: effects on susceptibility to meningococcal diseaseM J Callaghan, K Rockett, C Banner, et al.
The Journal of Infectious Diseases|April 22, 2008
School-aged children: a reservoir for continued circulation of Haemophilus influenzae type b in the United KingdomS Y Oh, D Griffiths, T John, et al.
Thorax|April 30, 2002
Increased resting bronchial tone in normal subjects acclimatised to altitudeC M Wilson, S E Bakewell, M R Miller, et al.
Infection and Immunity|May 4, 1999
Cellular immune responses to Neisseria meningitidis in childrenA J Pollard, R Galassini, E M Rouppe van der Voort, et al.
Physical Chemistry Chemical Physics : PCCP|August 9, 2014
Effects of temperature and ammonia flow rate on the chemical vapour deposition growth of nitrogen-doped grapheneA A Koós, A T Murdock, P Nemes-Incze, et al.
BMJ Open|October 30, 2015
Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adultsC A Green, E Scarselli, M Voysey, et al.
Clinical Science (London, England : 1979)|June 1, 1997
Hypoxia, hypocapnia and spirometry at altitudeA J Pollard, P W Barry, N P Mason, et al.
Pageof 9